A panelist discusses how payer contract requirements and reimbursement policies significantly influence their institution’s biosimilar adoption strategy, requiring careful analysis of net cost benefits when weighing potential savings against the operational complexities of managing multiple products.
Video content above is prompted by the following:
Get the latest industry news, event updates, and more from Managed healthcare Executive.